Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.9%),Peter Kolchinsky(5.9%), etc.
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Burrell Terry-Ann
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dar Zavain
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Li Dean Y
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data